'When You Look at This Chart, That Is Not My Whole Life': Caregiver Perspectives to Inform Improved Primary Care Practice and Outcomes

Autor: Monique Quinn, Allison Parsons, Chidiogo Anyigbo, Alexandra M. S. Corley, Lauren Lipps, Jamaica Gilliam, Julietta O. Ladipo, Caitlin Jee Hae Behle, Desiré Bennett, Carley Riley

Publikováno v: Journal of Primary Care & Community Health, Vol 15 (2024)

Objective: Worsening rates of infant and maternal mortality in the United States serve as an urgent call for multi-modal intervention. Infant Well Child Visits (WCVs) provide an opportunity for prevention, however not all infants receive the recommen

Externí odkaz: https://doaj.org/article/8f4528ba94b74a0492faf183d3a97e96

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Autor: Susan Sencer, Deanna Mitchell, Jessica Foley, Randal K. Wada, Joseph Junewick, Jeffrey P. Bond, Debra Pankiewicz, William Roberts, Monique Quinn, Jawhar Rawwas, William S. Ferguson, Javier Oesterheld, Giselle Saulnier Sholler, Jacqueline M. Kraveka, Valerie I. Brown, Kathleen A. Neville, Don Eslin, Francis Eshun, Genevieve Bergendahl, Peter E. Zage, Maria Rich, Nehal Parikh

Publikováno v: Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific reports, vol 8, iss 1
Sholler, Giselle L Saulnier; Ferguson, William; Bergendahl, Genevieve; Bond, Jeffrey P; Neville, Kathleen; Eslin, Don; et al.(2018). Maintenance DFMO Increases Survival in High Risk Neuroblastoma. SCIENTIFIC REPORTS, 8(1), 14445. doi: 10.1038/s41598-018-32659-w. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/4z74d9zw

High risk neuroblastoma (HRNB) accounts for 15% of all pediatric cancer deaths. Despite aggressive therapy approximately half of patients will relapse, typically with only transient responses to second-line therapy. This study evaluated the ornithine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6eab36b93d1ffcb93c4fdf96909f7bd
http://link.springer.com/article/10.1038/s41598-018-32659-w